Clinical Trial Update: CD8 DLI for Patients With Relapse or Residual Disease Following Allogeneic Stem Cell Transplantation [NA]

View source ↗

Summary

This clinical trial evaluated CD8 donor lymphocyte infusion for relapse or residual disease after allogeneic stem cell transplantation. The study included patie…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia
• Chronic Myeloid Leukemia
• Hodgkin Lymphoma
• Multiple Myeloma
• Non-hodgkin Lymphoma

Drugs mentioned

• CD8 donor lymphocyte infusion (CD8+ donor lymphocyte infusion)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Chronic Myelogenous Leukemia, Multiple Myeloma | NA | Status: TERMINATED